Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation

Last updated: January 17, 2018
Sponsor: Grupo de Estudos Multicentricos em Onco-Hematologia
Overall Status: Completed

Phase

3

Condition

Effects Of Chemotherapy

Multiple Myeloma

Bone Neoplasm

Treatment

N/A

Clinical Study ID

NCT03402295
GBRAM003r
  • Ages > 18
  • All Genders

Study Summary

This study compared two main different induction protocols used to treat myeloma eligible patients in Brazil. VCD against CTD.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • multiple myeloma newly diagnose elegible to autologous transplantation Patientssubmitted to ctd or vcd Myeloma patients newly diagnose >18yo

Exclusion

Exclusion Criteria:

  • other chemotherapy induction protocol

Study Design

Total Participants: 311
Study Start date:
June 15, 2009
Estimated Completion Date:
October 15, 2017

Study Description

The primary aim was observe response rate after 4 induction cycles.